On October 6, the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) released new data from the 2022 National Youth Tobacco Survey (NYTS) on the use of electronic cigarettes among American teenagers. "The FDA's data shows that youth e-cigarette use 'remains high,' but a closer look at the data reveals that experimental or infrequent use has only slightly increased while regular use has remained steady or slightly decreased," emphasized Abude in a statement.
According to data from the CDC, the number of high school students who have tried e-cigarettes (within the past 30 days) has decreased by 50% since 2019, while the number of middle school students has decreased by 70%. During the same period, the number of high school students who "frequently" use e-cigarettes has decreased by 37%, while the number of middle school students has decreased by 65%. "The FDA has been almost singularly focused on young people who try or frequently use e-cigarettes, ignoring the consistent trend of young people avoiding these products altogether. The FDA should not be focused on removing products from the market to try to influence youth e-cigarette use, but should support common-sense regulatory reforms to better restrict access to these products," said Abboud. "When these products are also proving to help adult smokers quit, simply removing them from the market is not the answer.
According to Abboud, it is well documented that flavored e-cigarette products can help adult smokers transition to less harmful e-cigarettes, as evidenced by numerous studies. He notes that smoking rates have decreased by over 50% since the widespread adoption of e-cigarettes in the US in 2010.
The use of tobacco has declined, as has the use of electronic cigarettes among teenagers, which is good news with no controversy. Unfortunately, 40 million Americans are still addicted to cigarettes," said Abdu. "Every year, 500,000 people die from smoking-related illnesses, but less than 3% of our children regularly use electronic cigarettes. The FDA has failed to acknowledge this reality, ignored the role of electronic cigarettes in reducing harm and quitting smoking, and put more lives at risk.
Statement:
This article is compiled from third-party information and is intended for internal industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of its content. The translation of this article is only intended for industry-related communication and research.
Due to limitations in our ability to accurately translate, this article may not fully express the sentiments of the original text. Please refer to the original article for accurate information.
2FIRSTS is fully aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
